HYPR earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -2.37. Updated 2026-07-23.
Hyperfine (HYPR) Research Hub
Hyperfine (HYPR) trades on NASDAQ, US in the Healthcare (Medical - Specialties) sector. As of 2026-09-11, shares last closed at 0.7901 USD (-0.10%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.37, market cap 0.08B. This hub links to the full technical, earnings and options research available for HYPR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Specialties) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7901 USD (-0.10%) |
| 52-week range | 0.7819 USD – 1.68 USD |
| Trend regime | Range |
| 14-day RSI | 19.9 (Oversold) |
| Trailing P/E | -2.37 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for HYPR
Covered Call on HYPR: how it works, illustrative setup around the real 0.7901 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HYPR: how it works, illustrative setup around the real 0.7901 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HYPR: how it works, illustrative setup around the real 0.7901 USD price, max profit/loss, breakeven and when to use it. Educational.
HYPR technical analysis: range, last 0.7901 USD, RSI 19.9, 52w range 0.7819 USD–1.68 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HYPR in?
Hyperfine (HYPR) is classified under Healthcare (Medical - Specialties), listed on NASDAQ, US.
Is HYPR in an uptrend or downtrend?
As of 2026-09-11, HYPR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HYPR's trailing P/E ratio?
HYPR's trailing P/E is -2.37, with a market cap of 0.08B. See the earnings research page for full valuation detail.
When does HYPR next report earnings?
HYPR is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.09 USD.